These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 37720315)

  • 21. Inflammatory stimuli differentially modulate the transcription of paracrine signaling molecules of equine bone marrow multipotent mesenchymal stromal cells.
    Vézina Audette R; Lavoie-Lamoureux A; Lavoie JP; Laverty S
    Osteoarthritis Cartilage; 2013 Aug; 21(8):1116-24. PubMed ID: 23685224
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The immunomodulation-immunogenicity balance of equine Mesenchymal Stem Cells (MSCs) is differentially affected by the immune cell response depending on inflammatory licensing and major histocompatibility complex (MHC) compatibility.
    Cequier A; Vázquez FJ; Romero A; Vitoria A; Bernad E; García-Martínez M; Gascón I; Barrachina L; Rodellar C
    Front Vet Sci; 2022; 9():957153. PubMed ID: 36337202
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mass spectrometric analysis of the in vitro secretome from equine bone marrow-derived mesenchymal stromal cells to assess the effect of chondrogenic differentiation on response to interleukin-1β treatment.
    Bundgaard L; Stensballe A; Elbæk KJ; Berg LC
    Stem Cell Res Ther; 2020 May; 11(1):187. PubMed ID: 32434555
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inflammatory priming enhances mesenchymal stromal cell secretome potential as a clinical product for regenerative medicine approaches through secreted factors and EV-miRNAs: the example of joint disease.
    Ragni E; Perucca Orfei C; De Luca P; Mondadori C; Viganò M; Colombini A; de Girolamo L
    Stem Cell Res Ther; 2020 Apr; 11(1):165. PubMed ID: 32345351
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The immunomodulatory function of equine MSCs is enhanced by priming through an inflammatory microenvironment or TLR3 ligand.
    Cassano JM; Schnabel LV; Goodale MB; Fortier LA
    Vet Immunol Immunopathol; 2018 Jan; 195():33-39. PubMed ID: 29249315
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of Stromal Cell Conditioned Medium and Antipurinergic Treatment on Macrophage Phenotype.
    Arabiyat AS; Yeisley DJ; Güiza-Argüello VR; Qureshi F; Culibrk RA; Hahn J; Hahn MS
    Tissue Eng Part C Methods; 2022 Dec; 28(12):656-671. PubMed ID: 36329666
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Exosomes from IL-1β-Primed Mesenchymal Stem Cells Inhibited IL-1β- and TNF-α-Mediated Inflammatory Responses in Osteoarthritic SW982 Cells.
    Kim M; Shin DI; Choi BH; Min BH
    Tissue Eng Regen Med; 2021 Aug; 18(4):525-536. PubMed ID: 33495946
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Regulatory-compliant conditions during cell product manufacturing enhance in vitro immunomodulatory properties of infrapatellar fat pad-derived mesenchymal stem/stromal cells.
    Kouroupis D; Bowles AC; Greif DN; Leñero C; Best TM; Kaplan LD; Correa D
    Cytotherapy; 2020 Nov; 22(11):677-689. PubMed ID: 32723596
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Allo-antibody production after intraarticular administration of mesenchymal stem cells (MSCs) in an equine osteoarthritis model: effect of repeated administration, MSC inflammatory stimulation, and equine leukocyte antigen (ELA) compatibility.
    Barrachina L; Cequier A; Romero A; Vitoria A; Zaragoza P; Vázquez FJ; Rodellar C
    Stem Cell Res Ther; 2020 Feb; 11(1):52. PubMed ID: 32028995
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Utility of a Mouse Model of Osteoarthritis to Demonstrate Cartilage Protection by IFNγ-Primed Equine Mesenchymal Stem Cells.
    Maumus M; Roussignol G; Toupet K; Penarier G; Bentz I; Teixeira S; Oustric D; Jung M; Lepage O; Steinberg R; Jorgensen C; Noel D
    Front Immunol; 2016; 7():392. PubMed ID: 27729913
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pro-inflammatory cytokines, IFNgamma and TNFalpha, influence immune properties of human bone marrow and Wharton jelly mesenchymal stem cells differentially.
    Prasanna SJ; Gopalakrishnan D; Shankar SR; Vasandan AB
    PLoS One; 2010 Feb; 5(2):e9016. PubMed ID: 20126406
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Large-scale secretome analyses unveil the superior immunosuppressive phenotype of umbilical cord stromal cells as compared to other adult mesenchymal stromal cells.
    Islam A; Urbarova I; Bruun JA; Martinez-Zubiaurre I
    Eur Cell Mater; 2019 Feb; 37():153-174. PubMed ID: 30785213
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Boosting the therapeutic potential of cell secretome against osteoarthritis: Comparison of cytokine-based priming strategies.
    Giannasi C; Della Morte E; Cadelano F; Valenza A; Casati S; Dei Cas M; Niada S; Brini AT
    Biomed Pharmacother; 2024 Jan; 170():115970. PubMed ID: 38042116
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Human multipotent mesenchymal stromal cells cytokine priming promotes RAB27B-regulated secretion of small extracellular vesicles with immunomodulatory cargo.
    Cheng A; Choi D; Lora M; Shum-Tim D; Rak J; Colmegna I
    Stem Cell Res Ther; 2020 Dec; 11(1):539. PubMed ID: 33317598
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A 3D cartilage - inflammatory cell culture system for the modeling of human osteoarthritis.
    Sun L; Wang X; Kaplan DL
    Biomaterials; 2011 Aug; 32(24):5581-9. PubMed ID: 21565399
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The systemic cellular immune response against allogeneic mesenchymal stem cells is influenced by inflammation, differentiation and MHC compatibility:
    Cequier A; Vázquez FJ; Vitoria A; Bernad E; Fuente S; Serrano MB; Zaragoza MP; Romero A; Rodellar C; Barrachina L
    Front Vet Sci; 2024; 11():1391872. PubMed ID: 38957800
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mesenchymal stem cell-derived secretome enhances nucleus pulposus cell metabolism and modulates extracellular matrix gene expression
    Tilotta V; Vadalà G; Ambrosio L; Cicione C; Di Giacomo G; Russo F; Papalia R; Denaro V
    Front Bioeng Biotechnol; 2023; 11():1152207. PubMed ID: 37008028
    [No Abstract]   [Full Text] [Related]  

  • 38. The effect of pro-inflammatory cytokines on immunophenotype, differentiation capacity and immunomodulatory functions of human mesenchymal stem cells.
    Pourgholaminejad A; Aghdami N; Baharvand H; Moazzeni SM
    Cytokine; 2016 Sep; 85():51-60. PubMed ID: 27288632
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immunomodulatory potential of mesenchymal stromal cell-derived extracellular vesicles in chondrocyte inflammation.
    Ossendorff R; Grad S; Tertel T; Wirtz DC; Giebel B; Börger V; Schildberg FA
    Front Immunol; 2023; 14():1198198. PubMed ID: 37564645
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Encapsulated Mesenchymal Stromal Cell Microbeads Promote Endogenous Regeneration of Osteoarthritic Cartilage Ex Vivo.
    Sahu N; Agarwal P; Grandi F; Bruschi M; Goodman S; Amanatullah D; Bhutani N
    Adv Healthc Mater; 2021 Apr; 10(8):e2002118. PubMed ID: 33434393
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.